HAMP and chronic kidney disease: A randomized, double-blind, placebo-controlled trial pilot study of VD-sup (n = 38, cholecalciferol, 50,000 IU weekly for 12 weeks) showed an increase in serum 25(OH)D and a decrease in serum hepcidin in subjects with early stage CKD [11].